XBiotech Inc. (XBIT)
NASDAQ: XBIT
· Real-Time Price · USD
3.20
-0.02 (-0.62%)
At close: Aug 21, 2025, 3:59 PM
3.20
0.00%
After-hours: Aug 21, 2025, 04:10 PM EDT
XBiotech Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.76M | -10.88M | -10.51M | -5.01M | -13.01M | -10M | -4.63M | -7.36M | -8.74M | -3.82M | -3.2M | -12.66M | -11.64M | -5.39M | -6.47M | -3.26M | -5.12M | -2.57M |
Depreciation & Amortization | 439K | 442K | 439K | 439K | 435K | 432K | 434K | 432K | 435K | 443K | 443K | 734K | 727K | 710K | 702K | 687K | 638K | 621K |
Stock-Based Compensation | 107K | 3.33M | 628K | 365K | 379K | 381K | 688K | 955K | 914K | 705K | 1.04M | 1.13M | 1.45M | 1.45M | 1.35M | 1.13M | 1.04M | 936K |
Other Working Capital | -2.03M | 1.58M | -1.86M | -849K | 1.14M | 407K | -101K | 3.75M | -720K | -693K | -1M | 7.26M | 1.56M | -574K | 1.95M | 544K | 75.61M | 544K |
Other Non-Cash Items | -3.08M | -284K | 4.1M | -707K | 554K | 1.58M | -1.25M | -824K | -127K | -324K | 3.27M | 350K | 422K | 5.25M | -533K | 5.47M | -70.03M | -2.06M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -128K | 1.89M | -1.2M | -59K | -465K | -350K | -422K | n/a | 533K | n/a | n/a | n/a |
Change in Working Capital | -1.7M | 677K | -1.2M | -927K | 262K | 405K | 1.33M | 3.42M | -276K | -1.76M | 1.63M | 4.77M | 3.09M | -1.89M | 2.65M | -1.96M | 76.24M | 2.82M |
Operating Cash Flow | -5.99M | -6.72M | -6.54M | -5.84M | -11.38M | -7.2M | -3.43M | -1.49M | -9M | -4.81M | 2.7M | -6.03M | -6.38M | -5.12M | -1.76M | -3.4M | 72.8M | 1.81M |
Capital Expenditures | -51K | -94K | -84K | -338K | -627K | -255K | -115K | -33K | -208K | -6K | -132K | -210K | -82K | -161K | -476K | -700K | -1.71M | -637K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.77M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 61.86M | n/a | n/a | -3.77M | -59.53M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -51K | -94K | -84K | -338K | -627K | -255K | -115K | 61.83M | -208K | -6K | -3.91M | -59.74M | -82K | -161K | -476K | -700K | -1.71M | -637K |
Debt Repayment | n/a | -10.25M | 250K | n/a | n/a | 10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -75M | -75M | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 33K | n/a | 48K | n/a | n/a | 5K | -14K | n/a | n/a | n/a | n/a | n/a | 33K | n/a | 3.98M | 1.02M |
Financial Cash Flow | n/a | -10.25M | 283K | 64K | 48K | 10.05M | n/a | 5K | 9.21M | n/a | n/a | n/a | n/a | n/a | 33K | -72.04M | 3.98M | 1.02M |
Net Cash Flow | -2.96M | -16.78M | -10.44M | -5.41M | -12.51M | 1.02M | -2.17M | 58.8M | -9.09M | -4.82M | -3.26M | -65.22M | -6.03M | -5.16M | -1.89M | -76.38M | 75.38M | 2.51M |
Free Cash Flow | -6.04M | -6.81M | -6.62M | -6.18M | -12M | -7.46M | -3.55M | -1.52M | -9.21M | -4.81M | 2.57M | -6.24M | -6.46M | -5.28M | -2.23M | -4.1M | 71.08M | 1.17M |